CN1095275A - A kind of injection for the treatment of prostatic hyperplasia - Google Patents
A kind of injection for the treatment of prostatic hyperplasia Download PDFInfo
- Publication number
- CN1095275A CN1095275A CN 93104744 CN93104744A CN1095275A CN 1095275 A CN1095275 A CN 1095275A CN 93104744 CN93104744 CN 93104744 CN 93104744 A CN93104744 A CN 93104744A CN 1095275 A CN1095275 A CN 1095275A
- Authority
- CN
- China
- Prior art keywords
- injection
- herba
- treatment
- prostatic hyperplasia
- lignocaine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of injection for the treatment of prostatic hyperplasia and preparation method thereof.It contains Talcum, Herba Patriniae, Rhizoma Curcumae, Endothelium Corneum Gigeriae Galli, Herba Taraxaci, Radix Paeoniae Rubra, Herba Taxilli, diethylstilbestrol, cephalosporin, dexamethasone, lignocaine, vitamin K
3, hyaluronidase.
Description
The present invention relates to a kind of medicine for the treatment of prostatic hyperplasia and preparation method thereof.Belong to field of traditional Chinese.
Prostatic hyperplasia is a kind of frequently-occurring disease, during pilosity is born in, old comrade.Show as frequent micturition, the thin or dysuria of urine line, even urine retention, very big misery brought to the patient.The medicine of treatment prostatic hyperplasia is many based on oral medicine at present, and the course of treatment is long, the curative effect limitation.Can not improve symptom all sidedly.Operative therapy is easy to generate serious complication, prostatic hyperplasia patient worn with age, and postoperative sickness rate and complication are more.Therefore still lack a kind of effective Comprehensive Treatment medicine at present for prostatic hyperplasia.
The object of the invention provides a kind of injection for the treatment of prostatic hyperplasia, and the preparation method of this injection.
To achieve the above object of the invention, the present invention adopts following preparation method.The prescription of injection partly is made up of Chinese medicine and Western medicine two, is main composition with Chinese medicine, is equipped with Western medicine, preparation cost invention injection.
1) preparation of Chinese medicinal ingredients
Talcum 20-25g Herba Patriniae 25-30g Rhizoma Curcumae 20-30g
Endothelium Corneum Gigeriae Galli 20-25g Herba Taraxaci 30-35g Radix Paeoniae Rubra 20-25g
Herba Taxilli 20-25g
Said medicine is mixed, and decocts with water, and filters, and gets filtrate, the condensed water decocting liquid, and autoclaving must extract concentrated solution 3-5ml.
2) western medicine composition preparation:
Diethylstilbestrol 1-2mg, cephalosporin 0.5-1.5g dilutes with normal saline 6-8ml, dexamethasone 5-10mg, 2% lignocaine 2-3ml, vitamin K
34-8ml, hyaluronidase 1500 units (U).
Chinese medicine extraction liquid 3-5ml mixed with above-mentioned Western medicine component promptly can be made into composite injection, sterilization, dress 5ml ampoule.
Therefore, the component content of injection of the present invention is:
Talcum 20-25g Herba Patriniae 25-30g Rhizoma Curcumae 20-30 gram
Endothelium Corneum Gigeriae Galli 20-25g Herba Taraxaci 30-35g Radix Paeoniae Rubra 20-25g
Herba Taxilli 20-25g
Diethylstilbestrol 1-2mg, cephalosporin 0.5-1.5g
Dexamethasone 5-10mg, 2% lignocaine 2-3ml
Vitamin K
34-8mg, hyaluronic acid 1500 μ
Above consumption has been represented the proportionate relationship between injection each component of the present invention, and those skilled in the art can arbitrarily enlarge or the minimizing consumption according to the above ratio by the actual production requirement, and this is all within protection domain of the present invention.
The advantage of injection of the present invention is: be applicable to old or with other multiple diseases can not the tolerate surgery treatment the patient, therapeutic effect is good, drug effect is fast, and is painful little, has no side effect.
Injection is used for the treatment of I
0, II
0, III
0Prostatic hyperplasia was generally 15-21 days the course of treatment, only needed injection 5-7 time, and inject after one time 4-6 hour and alleviate, effective percentage 100%, cure rate is more than 95%.
Treat 135 routine prostatic hyperplasia patients with composite injection of the present invention: wherein, before the 35 example injections: the segmentation of urinating, urine back eventually drips urine, in the daytime urinate 6-7 time, urinate 7-8 night, B ultrasonic prostate 4.8 * 4.2cm, it is normal substantially to urinate behind 3 injection injection of the present invention, in the daytime urinate 4-5 time, urinate 3-4 night, B ultrasonic prostate 3.8 * 3.2cm; Before the 54 example injections: the urine range is short, and the urine line is thin, urinates 7-8 time in the daytime, and urinate 8-10 night, B ultrasonic prostate 5.2 * 4.8cm; After injecting not the invention injection for 5 times, the urine range increases, and the chap of urine line is urinated 3-4 time in the daytime, and urinate 2-3 night, B ultrasonic prostate 3.6 * 3.1cm; Before the 46 example injections: dysuria, urine retention, indwelling catheter, B ultrasonic prostate 6.4 * 4.8cm, behind 7 injection injection of the present invention, it is normal to urinate, and can participate in normal work, B ultrasonic prostate 3.6 * 3.0cm.
Embodiment: take by weighing Talcum 20g, Herba Patriniae 25g, Rhizoma Curcumae 20g, Endothelium Corneum Gigeriae Galli 20g, Herba Taraxaci 30g, Radix Paeoniae Rubra 20g, Herba Taxilli 20g after the said mixture pulverizing, filters to get filtrate with decocting, concentrates, and autoclaving extracts Chinese medicine concentrated solution 5ml.
Get diethylstilbestrol 1mg, cephalosporin 0.5g is with normal saline 6ml dilution, dexamethasone 5mg, 2% lignocaine 2ml, vitamin K
34mg, hyaluronidase 1500 μ mixing is made into the Western medicine mixed liquor.
Above-mentioned Chinese medicine concentrated solution mixed with the Western medicine mixed liquor promptly get composite injection of the present invention.
Claims (2)
1, a kind of injection for the treatment of prostatic hyperplasia is characterized in that containing:
Talcum 20-25g, Herba Patriniae 25-30g,
Rhizoma Curcumae 20-30g, Endothelium Corneum Gigeriae Galli 20-25g,
Herba Taraxaci 30-35g, Radix Paeoniae Rubra 20-25g,
Herba Taxilli 20-25g, diethylstilbestrol 1-2mg,
Cephalosporin 0.5-1.5g, dexamethasone 5-10mg,
2% lignocaine 2-3ml, vitamin K
34-8mg,
Hyaluronic acid 1500 μ
2, a kind of injection preparation for the treatment of prostatic hyperplasia is characterized in that:
(1) with Talcum 20-25g, Herba Patriniae 25-30g, Rhizoma Curcumae 20-30g, Endothelium Corneum Gigeriae Galli 20-25g, Herba Taraxaci 30-35g, Radix Paeoniae Rubra 20-25g, Herba Taxilli 20-25g, decocting boils, and filters, and gets filtrate, concentrates, and autoclaving extracts concentrated solution 3-5ml;
(2) with above-mentioned concentrated solution 3-5ml, with diethylstilbestrol 1-2mg, cephalosporin 0.5-1.5g, normal saline 6-8ml dilution, dexamethasone 5-10mg, 2% lignocaine 2-3ml, vitamin K
34-8mg, hyaluronidase 1500 μ are hybridly prepared into composite injection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93104744 CN1095275A (en) | 1993-05-13 | 1993-05-13 | A kind of injection for the treatment of prostatic hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93104744 CN1095275A (en) | 1993-05-13 | 1993-05-13 | A kind of injection for the treatment of prostatic hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1095275A true CN1095275A (en) | 1994-11-23 |
Family
ID=4985337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93104744 Pending CN1095275A (en) | 1993-05-13 | 1993-05-13 | A kind of injection for the treatment of prostatic hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1095275A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012018948A3 (en) * | 2010-08-04 | 2012-10-26 | Pellficure Pharmaceuticals, Inc. | Combination therapy for the treatment of prostate carcinoma |
-
1993
- 1993-05-13 CN CN 93104744 patent/CN1095275A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012018948A3 (en) * | 2010-08-04 | 2012-10-26 | Pellficure Pharmaceuticals, Inc. | Combination therapy for the treatment of prostate carcinoma |
| CN103124563A (en) * | 2010-08-04 | 2013-05-29 | 佩尔菲丘尔制药有限公司 | Combination therapy for the treatment of prostate carcinoma |
| KR20130099928A (en) * | 2010-08-04 | 2013-09-06 | 펠피큐어 파마슈티걸즈 아이엔씨 | Combination therapy for the treatment of prostate carcinoma |
| US9132105B2 (en) | 2010-08-04 | 2015-09-15 | Pellficure Pharmaceuticals, Inc. | Treatment of prostate carcinoma |
| CN103124563B (en) * | 2010-08-04 | 2016-08-10 | 佩尔菲丘尔制药有限公司 | Therapeutic alliance for prostate cancer therapy |
| US9655868B2 (en) | 2010-08-04 | 2017-05-23 | Pellficure Pharmaceuticals, Inc. | Treatment of prostate carcinoma |
| US9877932B2 (en) | 2010-08-04 | 2018-01-30 | Pellficure Pharmaceuticals, Inc. | Treatment of prostate carcinoma |
| US10245240B2 (en) | 2010-08-04 | 2019-04-02 | Pellficure Pharmaceuticals, Inc. | Treatment of prostate carcinoma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7871647B1 (en) | Topical treatment of neuropathy | |
| CN108635437A (en) | A kind of pharmaceutical composition and its preparation method and application for treating mild acne | |
| CN101439114B (en) | Chinese medicine for treating burn and scald, and preparation method thereof | |
| CN115770279B (en) | Traditional Chinese medicine composition for treating chronic lower limb vein diseases, decoction and preparation thereof | |
| CN1095275A (en) | A kind of injection for the treatment of prostatic hyperplasia | |
| CN1137389A (en) | Method for preparation of medicine for external use and its emulsion for curing acne | |
| CN101549057A (en) | Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same | |
| CN111643540A (en) | Eucommia ulmoides extract for treating lumbar muscle strain and preparation method thereof | |
| CN1309402C (en) | Chinese drug for treating cholecystitis | |
| CN1108809C (en) | Medicine for treating leukoderma and preparing process thereof | |
| CN113491739B (en) | Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof | |
| CN1059800C (en) | Injection containing ginseng and astragalus root components | |
| CN114159536B (en) | Pharmaceutical composition, preparation method and application thereof | |
| CN116870076B (en) | Anti-inflammatory analgesic traditional Chinese medicine composition and preparation method and application thereof | |
| CN101574478B (en) | Western and traditional Chinese medicine tincture for treating acne mark | |
| CN1706447A (en) | Recipe and prepn process of piles treating Chinese medicine | |
| CN1241411A (en) | Pain-relieving stone-dissolving powder (bolus) | |
| CN116115698A (en) | Preparation of Runing granule and forming process thereof | |
| CN1061892C (en) | Oral liquid for treating tumor | |
| CN104491726A (en) | Traditional Chinese medicine composition for treating prostatic hyperplasia and preparation method of traditional Chinese medicine composition | |
| CN1118286C (en) | Specific oral liquid for treating various gastroenteristic diseases and its preparation | |
| CN116196372A (en) | Medicine for treating degenerative diseases of central nervous system and preparation method thereof | |
| CN1050759C (en) | Medicinal composite for hysteromyoma and preparing method | |
| CN1171964A (en) | Prescription of traditional Chinese medicine medicated bath | |
| CN111000941A (en) | Medicine for treating diabetes and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |